These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


140 related items for PubMed ID: 29597097

  • 21. Secreted portion of glycoprotein g of herpes simplex virus type 2 is a novel antigen for type-discriminating serology.
    Görander S, Svennerholm B, Liljeqvist JA.
    J Clin Microbiol; 2003 Aug; 41(8):3681-6. PubMed ID: 12904375
    [Abstract] [Full Text] [Related]

  • 22. Performance of the HerpeSelect (Focus) and Kalon enzyme-linked immunosorbent assays for detection of antibodies against herpes simplex virus type 2 by use of monoclonal antibody-blocking enzyme immunoassay and clinicovirological reference standards in Brazil.
    Nascimento MC, Ferreira S, Sabino E, Hamilton I, Parry J, Pannuti CS, Mayaud P.
    J Clin Microbiol; 2007 Jul; 45(7):2309-11. PubMed ID: 17507516
    [Abstract] [Full Text] [Related]

  • 23. Performance of HerpeSelect and Kalon assays in detection of antibodies to herpes simplex virus type 2.
    LeGoff J, Mayaud P, Gresenguet G, Weiss HA, Nzambi K, Frost E, Pepin J, Belec L, ANRS 12-12 Study Group.
    J Clin Microbiol; 2008 Jun; 46(6):1914-8. PubMed ID: 18385443
    [Abstract] [Full Text] [Related]

  • 24. The glycoproteins C and G are equivalent target antigens for the determination of herpes simplex virus type 1-specific antibodies.
    Scheper T, Saschenbrecker S, Steinhagen K, Sauerbrei A, Suer W, Meyer W, Schlumberger W, Wandinger KP.
    J Virol Methods; 2010 Jun; 166(1-2):42-7. PubMed ID: 20171247
    [Abstract] [Full Text] [Related]

  • 25. Evaluating the performance of the focus HerpeSelect® HSV-2 IgG in veterans with chronic hepatitis C infection.
    Burton M, Van Wagoner NJ, Sunesara I, Penman A, Swiatlo E, Hook EW.
    J Med Virol; 2015 Aug; 87(8):1377-81. PubMed ID: 25908332
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of confirmatory strategies for detection of type-specific antibodies against herpes simplex virus type 2.
    Eing BR, Lippelt L, Lorentzen EU, Hafezi W, Schlumberger W, Steinhagen K, Kühn JE.
    J Clin Microbiol; 2002 Feb; 40(2):407-13. PubMed ID: 11825950
    [Abstract] [Full Text] [Related]

  • 27. Rapid, sensitive, and specific lateral-flow immunochromatographic point-of-care device for detection of herpes simplex virus type 2-specific immunoglobulin G antibodies in serum and whole blood.
    Laderman EI, Whitworth E, Dumaual E, Jones M, Hudak A, Hogrefe W, Carney J, Groen J.
    Clin Vaccine Immunol; 2008 Jan; 15(1):159-63. PubMed ID: 18003814
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Evaluation of a near-patient test and 2 enzyme-linked immunosorbent assay-based assays for detecting anti-herpes simplex virus type-2 antibodies.
    Palù G, Calistri A, Cancellotti E, Cusan M, Mengoli C, Italian Herpes Forum.
    Scand J Infect Dis; 2001 Jan; 33(10):794-6. PubMed ID: 11728057
    [Abstract] [Full Text] [Related]

  • 31. Performance and use of HSV type-specific serology test kits.
    Ashley RL.
    Herpes; 2002 Jul; 9(2):38-45. PubMed ID: 12106510
    [Abstract] [Full Text] [Related]

  • 32. Performance and use of a ribonucleotide reductase herpes simplex virus type-specific serological assay.
    Wales SQ, Smith CC, Wachsman M, Calton G, Aurelian L.
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):42-9. PubMed ID: 14715543
    [Abstract] [Full Text] [Related]

  • 33. Time course of seroconversion by HerpeSelect ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2.
    Ashley-Morrow R, Krantz E, Wald A.
    Sex Transm Dis; 2003 Apr; 30(4):310-4. PubMed ID: 12671550
    [Abstract] [Full Text] [Related]

  • 34. Prevalence of herpes simplex virus types 1 and 2 among children and adolescents attending a sexual abuse clinic.
    Ramos S, Lukefahr JL, Morrow RA, Stanberry LR, Rosenthal SL.
    Pediatr Infect Dis J; 2006 Oct; 25(10):902-5. PubMed ID: 17006285
    [Abstract] [Full Text] [Related]

  • 35. Serologic Testing for Zika Virus: Comparison of Three Zika Virus IgM-Screening Enzyme-Linked Immunosorbent Assays and Initial Laboratory Experiences.
    Granger D, Hilgart H, Misner L, Christensen J, Bistodeau S, Palm J, Strain AK, Konstantinovski M, Liu D, Tran A, Theel ES.
    J Clin Microbiol; 2017 Jul; 55(7):2127-2136. PubMed ID: 28446573
    [Abstract] [Full Text] [Related]

  • 36. Validation of a membrane touch biosensor for the qualitative detection of IgG class antibodies to herpes simplex virus type 2.
    Loughman T, Singh B, Seddon B, Noone P, Santhosh P.
    Analyst; 2017 Jul 24; 142(15):2725-2734. PubMed ID: 28708188
    [Abstract] [Full Text] [Related]

  • 37. Escherichia coli expressed herpes simplex virus gG1 and gG2 proteins in ELISA and immunoblotting assays.
    Kakkanas A, Papadogeorgaki H, Manservigi R, Miriagou V, Georgopoulou U, Mavromara P.
    Intervirology; 1995 Jul 24; 38(6):346-51. PubMed ID: 8880385
    [Abstract] [Full Text] [Related]

  • 38. Use of "biokit HSV-2 Rapid Assay" to improve the positive predictive value of Focus HerpeSelect HSV-2 ELISA.
    Morrow RA, Friedrich D, Meier A, Corey L.
    BMC Infect Dis; 2005 Oct 14; 5():84. PubMed ID: 16225691
    [Abstract] [Full Text] [Related]

  • 39. Serologic herpes testing in the real world: validation of new type-specific serologic herpes simplex virus tests in a public health laboratory.
    Turner KR, Wong EH, Kent CK, Klausner JD.
    Sex Transm Dis; 2002 Jul 14; 29(7):422-5. PubMed ID: 12170133
    [Abstract] [Full Text] [Related]

  • 40. [ELISA study on application of recombinant glycoprotein D of herpes simplex virus-1 in diagnosis of herpes simplex virus-1 infection with ELISA].
    Wang ZY, Wang ZY, Wen HL, Tao ZX.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Jun 14; 19(2):159-61. PubMed ID: 16027786
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.